Title : Low dosed interferon alpha augments the anti-tumor potential of histone deacetylase inhibition on prostate cancer cell growth and invasion.

Pub. Date : 2012 Dec 1

PMID : 22473339






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We evaluated whether low-dosed interferon alpha (IFNa) may augment the anti-tumor potential of the histone deacetylase (HDAC)-inhibitor valproic acid (VPA) on prostate cancer cells in vitro and in vivo. Valproic Acid histone deacetylase 9 Homo sapiens
2 We evaluated whether low-dosed interferon alpha (IFNa) may augment the anti-tumor potential of the histone deacetylase (HDAC)-inhibitor valproic acid (VPA) on prostate cancer cells in vitro and in vivo. Valproic Acid histone deacetylase 9 Homo sapiens
3 We evaluated whether low-dosed interferon alpha (IFNa) may augment the anti-tumor potential of the histone deacetylase (HDAC)-inhibitor valproic acid (VPA) on prostate cancer cells in vitro and in vivo. Valproic Acid histone deacetylase 9 Homo sapiens
4 We evaluated whether low-dosed interferon alpha (IFNa) may augment the anti-tumor potential of the histone deacetylase (HDAC)-inhibitor valproic acid (VPA) on prostate cancer cells in vitro and in vivo. Valproic Acid histone deacetylase 9 Homo sapiens